U.S. markets closed
  • S&P 500

    3,821.55
    -78.56 (-2.01%)
     
  • Dow 30

    30,946.99
    -491.27 (-1.56%)
     
  • Nasdaq

    11,181.54
    -343.01 (-2.98%)
     
  • Russell 2000

    1,738.84
    -32.90 (-1.86%)
     
  • Crude Oil

    112.00
    +2.43 (+2.22%)
     
  • Gold

    1,821.80
    -3.00 (-0.16%)
     
  • Silver

    20.75
    -0.42 (-2.00%)
     
  • EUR/USD

    1.0523
    -0.0063 (-0.60%)
     
  • 10-Yr Bond

    3.2060
    +0.0120 (+0.38%)
     
  • GBP/USD

    1.2183
    -0.0087 (-0.71%)
     
  • USD/JPY

    136.1200
    +0.6740 (+0.50%)
     
  • BTC-USD

    20,278.05
    -626.92 (-3.00%)
     
  • CMC Crypto 200

    441.05
    -9.01 (-2.00%)
     
  • FTSE 100

    7,323.41
    +65.09 (+0.90%)
     
  • Nikkei 225

    27,049.47
    +178.20 (+0.66%)
     

Numinus to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

VANCOUVER, BC, June 21, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus") (TSX: NUMI) (OTC: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in the H.C. Wainwright 1st Annual Mental Health Conference to be held at the Lotte New York Palace Hotel in New York City on Monday, June 27, 2022.

Payton Nyquvest, Founder and CEO of Numinus, will present live virtually at 11:00 a.m. ET. To attend, please register here.

For more information about the conference, or to schedule a one-on-one meeting with Numinus' management, please contact your appropriate H.C. Wainwright representative directly, or send an email to KCSA Strategic Communications NuminusIR@kcsa.com.

About Numinus

Numinus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.

Disclaimer:

Neither Numinus Wellness Inc., nor any of its subsidiaries is a professional corporation licensed to practice health services. In jurisdictions where health services may only be provided by a corporation if that corporation holds a valid permit to do so, Numinus and its subsidiaries operate in a management services function to affiliated professional corporations, who provide health services to patients. Numinus and its subsidiaries do provide health services directly to patients in those jurisdictions where authorized to do so.

Forward-looking statements

Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-the-hc-wainwright-1st-annual-mental-health-conference-on-june-27-2022-301572442.html

SOURCE Numinus Wellness Inc.

Cision
Cision

View original content: http://www.newswire.ca/en/releases/archive/June2022/21/c3963.html